Analytics

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Articles

Time and sensitivity are essential for analytical technologies in all phases of biopharma development.

Emerging Analytical Technologies Advance Biopharma Development

After a long wait for the new elemental impurities guidelines, the bio/pharma industry must now look ahead to implementation and take action.

Moving On to Implementation for Elemental Impurities Testing

The countdown has begun for one of the biggest trade shows for the process industry.

ACHEMA Returns to Frankfurt

While biotech will revolutionize our industry through new products and new reaction pathways, process analytics is the link between process automation and the laboratory sector, and water plays a key role as a valuable resource all over the world.

ACHEMA Presents BioBasedWorld, Process Analytical Technology, and Industrial Water Management

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

The rapid testing of biologic raw materials can lead to greater efficiency.

Streamlining Raw Materials Testing

In this article, industry experts discuss critical analyses for demonstrating biosimilarity.

An Orthogonal Approach to Biosimilarity

Ligand-binding assays are fundamental to characterizing biosimilars.

Ligand-Binding Assays and the Determination of Biosimilarity

Advanced analytical methods are speeding up the targeted evaluation of potential viral contaminants.

The Challenge of Finding the Unknown

Methods must be suitable at each development phase, robust, and effective on multiple platforms.

Keys to Successful Method Transfer

Paul Kippax is a product manager, Laser Diffraction, Malvern Instruments Ltd., Enigma Business Park, Grovewood Road, Malvern Worcestershire, UK WR14 1XZ, Paul.Kippax@malvern.co.uk.

Analytical procedures and method validation should be developed with a structured and rigorous approach.

Analytical Method Development